Covid-19 roundup: Pfizer/BioNTech shot just as effective in real world, study says, as pair preps variant booster shots
The first real-world evidence for Pfizer/BioNTech’s Covid-19 vaccine is in, and there’s a lot for the companies to like.
Two months into the vaccine’s rollout …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
